XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' EQUITY
9 Months Ended
Sep. 30, 2022
STOCKHOLDERS' EQUITY  
STOCKHOLDERS' EQUITY

NOTE I – STOCKHOLDERS’ EQUITY

Accumulated Other Comprehensive Income

Components of accumulated other comprehensive income were as follows:

    

September 30

    

December 31

    

2022

    

2021

 

(in thousands)

Pre-tax amounts:

Unrecognized net periodic benefit credit

$

5,034

$

5,602

Interest rate swap

3,646

419

Foreign currency translation

 

(3,321)

 

(1,044)

Total

$

5,359

$

4,977

After-tax amounts:

Unrecognized net periodic benefit credit

$

3,738

$

4,160

Interest rate swap

2,692

309

Foreign currency translation

 

(2,452)

 

(770)

Total

$

3,978

$

3,699

The following is a summary of the changes in accumulated other comprehensive income, net of tax, by component for the nine months ended September 30, 2022 and 2021:

    

Unrecognized

Interest

Foreign

Net Periodic

Rate

Currency

    

Total

    

Benefit Credit

    

Swap

    

Translation

 

(in thousands)

Balances at December 31, 2021

$

3,699

$

4,160

$

309

$

(770)

Other comprehensive income (loss) before reclassifications

 

701

 

2,383

 

(1,682)

Amounts reclassified from accumulated other comprehensive income

 

(422)

 

(422)

 

Net current-period other comprehensive income (loss)

 

279

 

(422)

2,383

 

(1,682)

Balances at September 30, 2022

$

3,978

$

3,738

$

2,692

$

(2,452)

Balances at December 31, 2020

$

1,190

$

3,260

$

(1,198)

$

(872)

Other comprehensive income before reclassifications

997

869

128

Amounts reclassified from accumulated other comprehensive income

(300)

(300)

Net current-period other comprehensive income (loss)

697

(300)

869

128

Balances at September 30, 2021

$

1,887

$

2,960

$

(329)

$

(744)

The following is a summary of the significant reclassifications out of accumulated other comprehensive income by component:

Unrecognized Net Periodic

Benefit Credit(1)(2)

 

Nine Months Ended September 30

    

2022

    

2021

 

(in thousands)

 

Amortization of net actuarial gain, pre-tax

$

568

$

404

Tax expense

(146)

 

(104)

Total, net of tax

$

422

$

300

(1)Amounts in parentheses indicate increases in expense or loss.
(2)These components of accumulated other comprehensive income are included in the computation of net periodic benefit cost as disclosed in Note H.

Dividends on Common Stock

The following table is a summary of dividends declared during the applicable quarter:

2022

2021

    

Per Share

    

Amount

    

Per Share

    

Amount

 

(in thousands, except per share data)

First quarter

$

0.08

$

1,978

$

0.08

$

2,037

Second quarter

$

0.12

$

2,949

$

0.08

$

2,058

Third quarter

$

0.12

$

2,965

$

0.08

$

2,050

On October 28, 2022, the Company announced its Board of Directors declared a dividend of $0.12 per share to stockholders of record as of November 11, 2022.

Treasury Stock

The Company has a program to repurchase its common stock in the open market or in privately negotiated transactions (the “share repurchase program”). The share repurchase program has no expiration date but may be terminated at any time

at the Board of Directors’ discretion. Repurchases may be made using the Company’s cash reserves or other available sources. On November 2, 2021, the Company entered into a fixed dollar accelerated share repurchase program (“ASR”) with a third-party financial institution to effect an accelerated repurchase of $100.0 million of the Company’s common stock, of which $75.0 million was repurchased during 2021. The remaining $25.0 million available under the ASR was recorded as an unsettled forward contract within stockholders’ equity as additional paid-in capital as of December 31, 2021. The Company had $66.9 million available for repurchases of its common stock in total under the share repurchase program and the ASR as of December 31, 2021.

During the nine months ended September 30, 2022, the Company purchased 848,322 shares for an aggregate cost of $75.1 million, including the purchase of 214,763 shares to settle the remaining $25.0 million under the ASR. In April 2022, the Board of Directors reauthorized the share repurchase program and increased the total amount available for purchases of the Company’s common stock under the program to $75.0 million. The Company had $41.4 million remaining under its share repurchase programs as of September 30, 2022.